Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jul 2026 for Insight Molecular Diagnostics Inc., €39k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Lou Silverman: trading record in brief
This profile gathers the share dealings of Lou Silverman across 3 companies, led by Insight Molecular Diagnostics Inc., Staar Surgical Co and Veradigm Inc. Over a trading history stretching from 24 June 2021 to 1 July 2026, the count stands at 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 July 2026, the filings show a share grant worth €39k in Insight Molecular Diagnostics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lou Silverman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
7,700 shares@ US$5.69100.0% of flowCommon Stock, no par valueSEC:0001493152-26-032235:0
35,000 shares0Common Stock, no par valueSEC:0001641172-25-017796:0
46,512 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-081245:0
10,112 shares0Common StockSEC:0000950170-25-045626:0
25,000 shares0Common Stock, no par valueSEC:0001493152-23-022666:0
10,000 shares@ US$9.31100.0% of flowCommon StockSEC:0001209191-21-051095:0
807 shares0Common StockSEC:0001209191-21-043363:0
7 of 7 declarations
